Recent Company News

• 12:03 AM ET Oct 01, 2025
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 10:50 PM ET Sep 30, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 12:50 PM ET Sep 26, 2025
  

  White House says the latest pharmaceutical tariffs do not apply to countries with negotiated trade deals -- wires

• 08:15 PM ET Sep 25, 2025
  

  Trump says pharmaceutical products imported into US will be hit with 100% tariff starting 1-Oct - Truth Social post

• 09:49 AM ET Sep 25, 2025
  

  MicroPort Scientific holder Otsuka Holdings offers to sell 92.3M shares at HK$12.44-12.71/share - IFR (HK$13.52, 0.00)

• 07:43 AM ET Sep 20, 2025
  

  Otsuka, Lundbeck receive CRL from FDA for sNDA of REXULTI in combination with sertraline to treat adults with PTSD (¥8141.0000, 0)

• 02:11 AM ET Sep 19, 2025
  

  Otsuka Holdings receives approval for NEXLETOL (bempedoic acid) in Japan (¥8184.0000, +7)

• 01:32 AM ET Sep 11, 2025
  

  Cantargia closes acquisition of CAN10 by Otsuka (SEK 2.66, 0.00)

• 05:38 AM ET Sep 09, 2025
  

  Taiho Oncology, Cullinan Therapeutics present new data from REZILIENT1, REZILIENT2 trials of zipalertinib ($6.84, 0.00)

• 06:32 PM ET Sep 07, 2025
  

  Otsuka Holdings upgraded to buy from neutral at Mizuho Securities (¥8251.0000, 0)